Terms: = Kidney tumors AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB
77 results:
1. Cancer predisposition signaling in Beckwith-Wiedemann Syndrome drives Wilms tumor development.
Nirgude S; Naveh NSS; Kavari SL; Traxler EM; Kalish JM
Br J Cancer; 2024 Mar; 130(4):638-650. PubMed ID: 38142265
[TBL] [Abstract] [Full Text] [Related]
2. Modified Bushen Yiqi formula enhances antitumor immunity by reducing the chemotactic recruitment of M2-TAMs and PMN-MDSCs in Lewis lung cancer-bearing mice.
Kong Q; Zhu H; Gong W; Deng X; Liu B; Dong J
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117183. PubMed ID: 37739106
[TBL] [Abstract] [Full Text] [Related]
3. Gene expression studies of WT1 mutant Wilms tumor cell lines in the frame work of published kidney development data reveals their early kidney stem cell origin.
Royer-Pokora B; Wruck W; Adjaye J; Beier M
PLoS One; 2023; 18(1):e0270380. PubMed ID: 36689432
[TBL] [Abstract] [Full Text] [Related]
4. SCAND1 Reverses Epithelial-to-Mesenchymal Transition (EMT) and Suppresses Prostate Cancer Growth and Migration.
Eguchi T; Csizmadia E; Kawai H; Sheta M; Yoshida K; Prince TL; Wegiel B; Calderwood SK
Cells; 2022 Dec; 11(24):. PubMed ID: 36552758
[TBL] [Abstract] [Full Text] [Related]
5. Pancreatoblastoma in an elderly woman: A case report simulating a pancreatic neuroendocrine tumour with emphasis on cytomorphological features.
Saoud C; Wu AA; Fishman EK; Hruban RH; Ali SZ
Cytopathology; 2023 May; 34(3):254-258. PubMed ID: 36546760
[TBL] [Abstract] [Full Text] [Related]
6. Differential requirement of Hippo cascade during ctnnb1 or AXIN1 mutation-driven hepatocarcinogenesis.
Liang B; Wang H; Qiao Y; Wang X; Qian M; Song X; Zhou Y; Zhang Y; Shang R; Che L; Chen Y; Huang Z; Wu H; Monga SP; Zeng Y; Calvisi DF; Chen X; Chen X
Hepatology; 2023 Jun; 77(6):1929-1942. PubMed ID: 35921500
[TBL] [Abstract] [Full Text] [Related]
7. Multiregion sequencing of sarcomatoid renal cell carcinoma arising from autosomal dominant polycystic kidney disease.
Lee E; Guan P; Lim AH; Loh JW; Tan GF; Loh T; Ng DYX; Lee JY; Goh S; Liu W; Ng CC; Teh BT; Chan JY
Mol Genet Genomic Med; 2022 Mar; 10(3):e1853. PubMed ID: 35122417
[TBL] [Abstract] [Full Text] [Related]
8. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.
Zhang S; Xu X; Wang Y; Zhu Y; Wang J; Wang H; Guo J
Ann Clin Lab Sci; 2021 Sep; 51(5):597-608. PubMed ID: 34686501
[TBL] [Abstract] [Full Text] [Related]
9. Association of Damaging Variants in Genes With Increased Cancer Risk Among Patients With Congenital Heart Disease.
Morton SU; Shimamura A; Newburger PE; Opotowsky AR; Quiat D; Pereira AC; Jin SC; Gurvitz M; Brueckner M; Chung WK; Shen Y; Bernstein D; Gelb BD; Giardini A; Goldmuntz E; Kim RW; Lifton RP; Porter GA; Srivastava D; Tristani-Firouzi M; Newburger JW; Seidman JG; Seidman CE
JAMA Cardiol; 2021 Apr; 6(4):457-462. PubMed ID: 33084842
[TBL] [Abstract] [Full Text] [Related]
10. A rare sporadic pancreatic desmoid fibromatosis diagnosed by endoscopic ultrasound-guided fine-needle aspiration: Case report and literature review.
Stone AB; Mallery JS; Stewart J; Amin K
Diagn Cytopathol; 2021 Feb; 49(2):E49-E54. PubMed ID: 32857922
[TBL] [Abstract] [Full Text] [Related]
11. WT1-Mutant Wilms Tumor Progression Is Associated With Diverting Clonal Mutations of ctnnb1.
Duhme C; Busch M; Heine E; de Torres C; Mora J; Royer-Pokora B
J Pediatr Hematol Oncol; 2021 Mar; 43(2):e180-e183. PubMed ID: 31876779
[TBL] [Abstract] [Full Text] [Related]
12. Comprehensive Analysis of Driver Genes in Personal Genomes of Clear Cell Renal Cell Carcinoma.
Li J; Guo L; Chai L; Ai Z
Technol Cancer Res Treat; 2019 Jan; 18():1533033819830966. PubMed ID: 30852945
[TBL] [Abstract] [Full Text] [Related]
13. Correlations between Histological and Array Comparative Genomic Hybridization Characterizations of Wilms Tumor.
Chiang MR; Kuo CW; Wang WC; Hou TC; Kuo CY; Lu MY; Lai YC
Pathol Oncol Res; 2019 Jul; 25(3):1199-1206. PubMed ID: 30671724
[TBL] [Abstract] [Full Text] [Related]
14. RNAi-Mediated β-Catenin Inhibition Promotes T Cell Infiltration and Antitumor Activity in Combination with Immune Checkpoint Blockade.
Ganesh S; Shui X; Craig KP; Park J; Wang W; Brown BD; Abrams MT
Mol Ther; 2018 Nov; 26(11):2567-2579. PubMed ID: 30274786
[TBL] [Abstract] [Full Text] [Related]
15. Molecular and epidemiologic characterization of Wilms tumor from Baghdad, Iraq.
Phelps HM; Al-Jadiry MF; Corbitt NM; Pierce JM; Li B; Wei Q; Flores RR; Correa H; Uccini S; Frangoul H; Alsaadawi AR; Al-Badri SAF; Al-Darraji AF; Al-Saeed RM; Al-Hadad SA; Lovvorn Iii HN
World J Pediatr; 2018 Dec; 14(6):585-593. PubMed ID: 30155617
[TBL] [Abstract] [Full Text] [Related]
16. Identifying a panel of genes/proteins/miRNAs modulated by arsenicals in bladder, prostate, kidney cancers.
Polo A; Marchese S; De Petro G; Montella M; Ciliberto G; Budillon A; Costantini S
Sci Rep; 2018 Jul; 8(1):10395. PubMed ID: 29991691
[TBL] [Abstract] [Full Text] [Related]
17. Convergent evolution of 11p allelic loss in multifocal Wilms tumors arising in WT1 mutation carriers.
Valind A; Wessman S; Pal N; Karlsson J; Jonson T; Sandstedt B; Gisselsson D
Pediatr Blood Cancer; 2018 Nov; 65(11):e27301. PubMed ID: 29968962
[TBL] [Abstract] [Full Text] [Related]
18. Basal-Cell Carcinoma With Matrical Differentiation: Report of a New Case in a Renal-Transplant Recipient and Literature Review.
Kanitakis J; Ducroux E; Hoelt P; Cahen R; Jullien D
Am J Dermatopathol; 2018 Aug; 40(8):e115-e118. PubMed ID: 29863570
[TBL] [Abstract] [Full Text] [Related]
19. Utilization of Stereotactic Radiosurgery for Renal Cell Carcinoma Brain Metastases.
Haque W; Verma V; Butler EB; Teh BS
Clin Genitourin Cancer; 2018 Aug; 16(4):e935-e943. PubMed ID: 29680768
[TBL] [Abstract] [Full Text] [Related]
20. Chemotherapy and terminal skeletal muscle differentiation in WT1-mutant Wilms tumors.
Royer-Pokora B; Beier M; Brandt A; Duhme C; Busch M; de Torres C; Royer HD; Mora J
Cancer Med; 2018 Apr; 7(4):1359-1368. PubMed ID: 29542868
[TBL] [Abstract] [Full Text] [Related]
[Next]
